In a large cohort of patients with COVID-19, systemic inflammation—as detected by increased levels of IL-6, hsCRP or ferritin—was highly correlated with the degree of ALI, as assessed by AST levels [25,26]. The gene discussed is IL6; the disease is COVID-19.